Inventor
HATANAKA HIROSHI
JP44 patents
⚠️ This page may combine multiple inventors who share the name “HATANAKA HIROSHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FUJISAWA PHARMACEUTICAL CO
27 patentsUS4894366AJan 16, 1990
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO214 citations99
US4929611AMay 29, 1990
Method for immunosuppression
FUJISAWA PHARMACEUTICAL CO105 citations97
US5624842AApr 29, 1997
Strain of Streptomyces for the production of tricyclo compounds
FUJISAWA PHARMACEUTICAL CO35 citations96
US5496727AMar 5, 1996
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO22 citations96
US4956352ASep 11, 1990
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO48 citations96
US5254562AOct 19, 1993
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO25 citations92
US6576135B1Jun 10, 2003
Method for separating lactone-containing high-molecular weight compounds
FUJISAWA PHARMACEUTICAL CO24 citations90
US6492513B1Dec 10, 2002
Method for separating analogous organic compounds
FUJISAWA PHARMACEUTICAL CO29 citations89
US6028097AFeb 22, 2000
Method of immunosuppression
FUJISAWA PHARMACEUTICAL CO8 citations82
US5830717ANov 3, 1998
Process for production of tricyclo compounds with streptomyces
FUJISAWA PHARMACEUTICAL CO9 citations82
US5565559AOct 15, 1996
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO8 citations82
US5110811AMay 5, 1992
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO20 citations82
US6482845B1Nov 19, 2002
Method for inhibiting interleukin-2 production using tricyclo compounds
FUJISAWA PHARMACEUTICAL CO2 citations74
US6201005B1Mar 13, 2001
Method for inhibiting lymphokine production
FUJISAWA PHARMACEUTICAL CO5 citations74
US5266692ANov 30, 1993
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO12 citations74
US5061730AOct 29, 1991
Carboxylic acid derivatives
FUJISAWA PHARMACEUTICAL CO6 citations72
US6881341B2Apr 19, 2005
Method for separating lactone-containing high-molecular weight compounds
FUJISAWA PHARMACEUTICAL CO11 citations71
US5854276ADec 29, 1998
Substance WF16616, process for production thereof, and use thereof
FUJISAWA PHARMACEUTICAL CO7 citations70
US5279826AJan 18, 1994
Prophylactic/therapeutic composition for disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis
FUJISAWA PHARMACEUTICAL CO6 citations69
US5409701AApr 25, 1995
FR901451 substance, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO5 citations63
US6331521B1Dec 18, 2001
Echinocandine derivatives with antimicrobial activity
FUJISAWA PHARMACEUTICAL CO4 citations62
US5364624ANov 15, 1994
WS7622A mono- or di-sulfate, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO2 citations62
US5292510AMar 8, 1994
WS7622A mono- or di- sulfate, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO2 citations62
US5167958ADec 1, 1992
WS7622A, B, C and D substances, derivatives thereof, processes for preparation thereof and use for treatment of pulmonary emphysema and adult respiratory distress syndrome
FUJISAWA PHARMACEUTICAL CO3 citations62
US5021240AJun 4, 1991
WS7622A, B, C and D substances, derivatives thereof, processes for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO5 citations62
US6399567B1Jun 4, 2002
Cyclic hexapeptides having antibiotic activity
FUJISAWA PHARMACEUTICAL CO4 citations61
US4963585AOct 16, 1990
Compound, WF11605 and derivative thereof
FUJISAWA PHARMACEUTICAL CO0 citations51